Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.
about
Computational Modeling in Liver Surgery.No significant impact of Foxf1 siRNA treatment in acute and chronic CCl4 liver injury.Serum and Hepatic Autofluorescence as a Real-Time Diagnostic Tool for Early Cholestasis Assessmentβ-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids Farnesoid X Receptor and Constitutive Androstane Receptor
P2860
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.
@ast
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.
@en
type
label
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.
@ast
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.
@en
prefLabel
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.
@ast
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.
@en
P2093
P2860
P50
P1433
P1476
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.
@en
P2093
Andreas Hoppe
Brigitte Vollmar
Herrmann-Georg Holzhütter
Honglei Weng
Isabell Müller
Johannes Bode
Kerstin Abshagen
Matthias Ebert
Steven Dooley
P2860
P2888
P356
10.1186/S12918-015-0229-0
P577
2015-11-20T00:00:00Z